The Blog
MindWalk (Nasdaq: HYFT) is a Bio-Native AI company. Our HYFT® Technology and ReefIQ™ context layer ground AI in real biology for drug discovery.
Antibodies in the clinic
20+ publicly disclosed client antibodies have advanced to clinical development. Ten in the clinic today, four first in class. Publicly disclosed programs only. Additional client antibodies have advanced under client confidentiality.
See the record